Literature DB >> 34888835

Astrocytes in Neuropsychiatric Disorders: A Review of Postmortem Evidence.

Xiaolu Zhang1, Rawan S Alnafisah1, Abdul-Rizaq A Hamoud1, Rammohan Shukla1, Robert E McCullumsmith1,2, Sinead M O'Donovan3.   

Abstract

Glial cell types in the central nervous system (CNS) include microglia, oligodendrocytes and the most diverse type, astrocytes. Clinical and experimental evidence suggest critical roles for astrocytes in the pathogenesis of CNS disease. Here, we summarize the extensive morphological heterogeneity and physiological properties of different astrocyte subtypes. We review postmortem studies, discussing astrocyte-related changes found in the brain in subjects diagnosed with the neuropsychiatric disorders schizophrenia, major depressive disorder and bipolar disorder. Finally, we discuss the potential effects of psychotropic medication on these findings. In summary, postmortem studies highlight that the morphology of astrocytes and the expression of functionally important astrocyte markers are altered in the brain in neuropsychiatric disorders and may play a role in the pathophysiology of these serious mental illnesses.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Astrocyte; Bipolar disorder; Major depressive disorder; Postmortem; Schizophrenia

Mesh:

Year:  2021        PMID: 34888835     DOI: 10.1007/978-3-030-77375-5_8

Source DB:  PubMed          Journal:  Adv Neurobiol


  127 in total

1.  Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia.

Authors:  S E Arnold; B R Franz; J Q Trojanowski; P J Moberg; R E Gur
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

Review 2.  Tripartite synapses: glia, the unacknowledged partner.

Authors:  A Araque; V Parpura; R P Sanzgiri; P G Haydon
Journal:  Trends Neurosci       Date:  1999-05       Impact factor: 13.837

3.  The Neuroglia Elements in the Human Brain.

Authors:  W L Andriezen
Journal:  Br Med J       Date:  1893-07-29

4.  Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.

Authors:  Deborah Bauer; Daya Gupta; Vahram Harotunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2008-08-03       Impact factor: 4.939

5.  Circulating levels of GDNF in bipolar disorder.

Authors:  Izabela Guimarães Barbosa; Rodrigo Barreto Huguet; Lirlândia Pires Sousa; Mery Natali Silva Abreu; Natália Pessoa Rocha; Moisés Evandro Bauer; Lívia A Carvalho; Antônio Lúcio Teixeira
Journal:  Neurosci Lett       Date:  2011-07-28       Impact factor: 3.046

Review 6.  Bipolar depression: overview and commentary.

Authors:  Ross J Baldessarini; Eduard Vieta; Joseph R Calabrese; Mauricio Tohen; Charles L Bowden
Journal:  Harv Rev Psychiatry       Date:  2010 May-Jun       Impact factor: 3.732

7.  Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder.

Authors:  Lori L Altshuler; Osama A Abulseoud; Lara Foland-Ross; George Bartzokis; Sean Chang; Jim Mintz; Gerhard Hellemann; Harry V Vinters
Journal:  Bipolar Disord       Date:  2010-08       Impact factor: 6.744

8.  Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.

Authors:  Kevin Barley; Stella Dracheva; William Byne
Journal:  Schizophr Res       Date:  2009-05-17       Impact factor: 4.939

9.  Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia.

Authors:  Deborah Bauer; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2009-08-27       Impact factor: 4.939

View more
  1 in total

Review 1.  Looking to the stars for answers: Strategies for determining how astrocytes influence neuronal activity.

Authors:  Jacqueline E Paniccia; James M Otis; Michael D Scofield
Journal:  Comput Struct Biotechnol J       Date:  2022-08-02       Impact factor: 6.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.